Sio Gene Therapies (SIOX) Short Interest Ratio & Short Volume

Short interest is the volume of Sio Gene Therapies shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 140,900 shares of SIOX short. 0.26% of Sio Gene Therapies' shares are currently sold short. Learn More on Sio Gene Therapies' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.26% of Sio Gene Therapies' floating shares are currently sold short.

Sio Gene Therapies saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 140,900 shares, an increase of 97.3% from the previous total of 71,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Sio Gene Therapies currently has issued a total of 0 shares. Some of Sio Gene Therapies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sio Gene Therapies currently has a public float of 53,450,000 shares.

0.26% of Sio Gene Therapies' shares are currently sold short. Here is how the short interest of companies compare to Sio Gene Therapies: Eli Lilly and Company (0.87%), Johnson & Johnson (0.95%), AbbVie Inc. (1.13%), Novo Nordisk A/S (0.62%), Novartis AG (0.18%), Abbott Laboratories (1.29%), AstraZeneca PLC (0.24%), Merck & Co., Inc. (1.64%), Pfizer Inc. (1.90%), Sanofi (0.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling SIOX is an investing strategy that aims to generate trading profit from Sio Gene Therapies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sio Gene Therapies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SIOX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SIOX, twice per month. The most recent reporting period available is March, 15 2023.